You are here

Article info

Article menu

Download PDFPDF

Regional plenary
Breast Plenary
IGCS19-0128
66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis
Free

Authors

  • L Sun 1London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK 2Barts Cancer Institute- Queen Mary University of London, Centre for Experimental Cancer Medicine, London, UK PubMed articlesGoogle scholar articles
  • A Brentnall 3Wolfson Institute of Preventive Medicine- Queen Mary University of London, Centre for Cancer Prevention, London, UK PubMed articlesGoogle scholar articles
  • S Patel 2Barts Cancer Institute- Queen Mary University of London, Centre for Experimental Cancer Medicine, London, UK PubMed articlesGoogle scholar articles
  • D Buist SM 4Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington Health Research Institute, Seattle, USA PubMed articlesGoogle scholar articles
  • E Bowles JA 4Kaiser Permanente Washington Health Research Institute, Kaiser Permanente Washington Health Research Institute, Seattle, USA PubMed articlesGoogle scholar articles
  • DG Evans R 5The University of Manchester, Genomic Medicine- Manchester Academic Health Science Centre MAHSC- Manchester Universities Foundation Trust- St. Mary’s Hospital, London, UK PubMed articlesGoogle scholar articles
  • D Eccles 6University of Southampton, Cancer Sciences Academic Unit- Faculty of Medicine and Cancer Sciences, Southampton, UK PubMed articlesGoogle scholar articles
  • J Hopper 7University of Melbourne, Centre for Epidemiology and Biostatistics- Melbourne School of Population and Global Health- Faculty of Medicine- Dentistry and Health Sciences, Melbourne, Australia PubMed articlesGoogle scholar articles
  • S Li 7University of Melbourne, Centre for Epidemiology and Biostatistics- Melbourne School of Population and Global Health- Faculty of Medicine- Dentistry and Health Sciences, Melbourne, Australia PubMed articlesGoogle scholar articles
  • S Duffy 3Wolfson Institute of Preventive Medicine- Queen Mary University of London, Centre for Cancer Prevention, London, UK PubMed articlesGoogle scholar articles
  • J Cuzick 3Wolfson Institute of Preventive Medicine- Queen Mary University of London, Centre for Cancer Prevention, London, UK PubMed articlesGoogle scholar articles
  • I dos-Santos-Silva 8London School of Hygiene and Tropical Medicine, Department of Non-communicable Disease Epidemiology, London, UK PubMed articlesGoogle scholar articles
  • Z Sadique 1London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK PubMed articlesGoogle scholar articles
  • L Yang 9Peking University, School of Public Health, Beijing, China PubMed articlesGoogle scholar articles
  • R Legood 1London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK PubMed articlesGoogle scholar articles
  • R Manchanda 2Barts Cancer Institute- Queen Mary University of London, Centre for Experimental Cancer Medicine, London, UK 10Barts Health NHS Trust- Royal London Hospital, Department of Gynaecological Oncology, London, UK 11University College London, MRC Clinical Trials Unit at UCL- Institute of Clinical Trials and Methodology- Faculty of Population Health Sciences, London, UK PubMed articlesGoogle scholar articles

Citation

Sun L, Brentnall A, Patel S, et al
66 Should we offer multi-gene testing to all patients with breast cancer: a cost-effectiveness analysis
International Journal of Gynecologic Cancer 2019;29:A36-A37.

Publication history

  • First published September 18, 2019.
Online issue publication 
September 18, 2019

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.